EAM
IRWD icon

Eventide Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Eventide Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-740,554
Closed -$8.47M – 168
2023
Q4 		$8.47M Buy
+740,554
New +$7.33M 0.14% 126
2018
Q4 		– Sell
-229,248
Closed -$3.54M – 143
2018
Q3 		$3.54M Hold
229,248
– – 0.13% 105
2018
Q2 		$3.67M Hold
229,248
– – 0.15% 98
2018
Q1 		$2.96M Hold
229,248
– – 0.14% 99
2017
Q4 		$2.88M Hold
229,248
– – 0.15% 96
2017
Q3 		$3.03M Hold
229,248
– – 0.17% 91
2017
Q2 		$3.63M Buy
+229,248
New +$3.33M 0.23% 83

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Eventide Asset Management's IRWD Position: Q1 2024 in Review

Eventide Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2024, closing a stake of 740,554 shares — an estimated $8.47M sold.

Eventide Asset Management first reported a position in IRWD in Q2 2017 and held it in 7 quarters. The position peaked at $8.47M in Q4 2023. 261 funds tracked by Wall St. Rank hold IRWD as of Q1 2024.

  • Eventide Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Eventide Asset Management sold 740,554 Ironwood Pharmaceuticals shares in Q1 2024, an estimated $8.47M.
  • Eventide Asset Management first reported a position in Ironwood Pharmaceuticals in Q2 2017 and held it in 7 quarters.
  • Eventide Asset Management's Ironwood Pharmaceuticals position peaked at $8.47M in Q4 2023.
  • 261 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2024.

Based on Eventide Asset Management's 13F filing for Q1 2024, filed 15 May 2024.